A Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy (MK-3102-024)
Clinical trial NCT01755156 · COMPLETED
Trial details
- NCT number
- NCT01755156
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-11
- Primary completion
- 2016-03-16
- Enrollment
- 402
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.